Adrenocorticotropic hormone (ACTH) release from anterior pituitary corticotropes is greatly increased during peripheral inflammation induced by lipopolysaccharide (LPS) administration. Interleukin-6 (IL-6) is thought to participate in LPS-induced ACTH release, but whether or not corticotropes are directly targeted by this cytokine is unclear. Therefore, we investigated the expression and activation of IL-6 signaling components in the pituitary of rats 2 and 4 h after administration of LPS (250 µg/kg). Intraperitoneal LPS treatment provoked the nuclear translocation of signal transducer and activator of transcription 3 (STAT-3) and Fos expression in the anterior pituitary lobe, as demonstrated by immunohistochemistry. By using in situ hybridization, we demonstrated that suppressor of cytokine signaling 3 (SOCS-3) and c-fos mRNAs were significantly induced by the LPS treatment in the anterior lobe of the pituitary. Dual in situ hybridization revealed that most corticotropes expressed IL-6 receptor and gp130 mRNAs, and that 2 h after LPS treatment, SOCS-3 and c-fos mRNAs were induced in corticotropes. Our results suggest that LPS-induced IL-6 could regulate the hypothalamo-pituitary-adrenal axis by directly targeting corticotropes during peripheral inflammation.

Keywords:
Proopiomelanocortin, In situ hybridization, Immunocytochemistry, STAT-3, Fos, Lipopolysaccharide, Interleukins, Inflammation, Neuroimmune interactions, Corticotropes
1.
Gadient RA, Patterson PH: Leukemia inhibitory factor, interleukin 6, and other cytokines using gp130 transducing receptor: Roles in inflammation and injury. Stem Cells 1999;17:127–137.
2.
Taga T, Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797–819.
3.
Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 1998;334:297–314.
4.
Starr R, Willson TA, Viney EM, Murray LJL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ: A family of cytokine-inducible inhibitors of signaling. Nature 1997;387:917–921.
5.
McEwen BS, Biron CA, Brunson KW, Bulloch K, Chambers WH, Dhabhar FS, Goldfarb RH, Kitson RP, Miller AH, Spencer RL, Weiss JM: The role of adrenocorticoids as modulator of immune function in health and disease: Neural, endocrine and immune interactions. Brain Res Brain Res Rev 1997;23:79–133.
6.
Lyson K, McCann SM: The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 1991;54:262–266.
7.
Lyson K, McCann SM: Induction of adrenocorticotropic hormone release by interleukin-6 in vivo and in vitro. Ann NY Acad Sci 1992;650:182–185.
8.
Matta SG, Weatherbee J, Sharp BM: A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: Comparison to and interaction with IL-1 beta. Neuroendocrinology 1992;56:516–525.
9.
Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H: Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 1988;155:1459–1463.
10.
Lyson K, McCann SM: Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Neuroendocrinology 1992;55:708–713.
11.
Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB: Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991;128:37–44.
12.
Perlstein RS, Withnall MH, Abrams JS, Mougey EH, Neta R: Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993;132:946–952.
13.
Van Enckevort FH, Sweep CG, Span PN, Demacker PN, Hermsen CC, Hermus AR: Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. J Endocrinol Invest 2001;24:786–795.
14.
Vallières L, Rivest S: Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 1999;140:3890–3903.
15.
Shimon I, Yan X, Ray DW, Melmed S: Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest 1997;100:357–363.
16.
Fukata J, Usui T, Naitoh Y, Nakai Y, Imura H: Effects of recombinant human interleukin-1 alpha, -1 beta, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol 1989;122:33–39.
17.
Katahira M, Iwasaki Y, Aoki Y, Oiso Y, Saito H: Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 1998;139:2414–2422.
18.
Bethin KE, Vogt SK, Muglia LJ: Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA 2000;97:9317–9322.
19.
Ohmichi M, Hirota K, Koike K, Kurachi H, Ohtsuka S, Matsuzaki N, Yamaguchi M, Miyake A, Tanizawa O: Binding sites for interleukin-6 in the anterior pituitary gland. Neuroendocrinology 1992;55:199–203.
20.
Grinevitch V, Ma XM, Herman JP, Jezova D, Akmayev I, Aguilera G: Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamo-pituitary-adrenal axis activity in rats. J Neuroendocrinol 2001;13:711–723.
21.
Velkeniers B, Vergani P, Trouillas J, D’Haens J, Hooghe RJ, Hooghe-Peters EL: Expression of IL-6 mRNA in normal rat and human pituitaries and in human pituitary adenomas. J Histochem Cytochem 1994;42:67–76.
22.
Gautron L, Lafon P, Chaigniau M, Tramu G, Layé S: Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge. Neuroscience 2002;112:717–729.
23.
Vallières L, Rivest S: Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β. J Neurochem 1997;69:1668–1683.
24.
Bjørbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS: Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619–625.
25.
Chowen-Breed J, Fraser HM, Vician L, Damassa DA, Clifton DK, Steiner RA: Testosterone regulation of proopiomelanocortin messenger ribonucleic acid in the arcuate nucleus of the male rat. Endocrinology 1989;124:1697–1702.
26.
Ek M, Kurosawa M, Lundeberg T, Ericsson A: Activation of vagal afferents after intravenous injection of interleukin-1beta: Role of endogenous prostaglandins. J Neurosci 1998;18:9471–9479.
27.
Juaneda C, Lafon-Dubourg P, Ciofi P, Sarrieau A, Corio M, Tramu G: Immune challenge-stimulated hypophysiotropic corticotropin-releasing hormone messenger RNA expression is associated with an induction of neurotensin messenger RNAs without alteration of vasopressin messenger RNAs. Neuroscience 1999;93:393–400.
28.
Arzt E: Gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuro-endocrine pathways. J Clin Invest 2001;108:1729–1733.
29.
Lohrer P, Gloddek J, Carbia Nagashima A, Korali Z, Hopfner U, Paez Pereda M, Arzt E, Stalla GK, Renner U: Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38α mitogen-activated protein kinase/nuclear factor-κB pathway. Endocrinology 2000;141:4457–4465.
30.
Chesnokova V, Kariagina A, Melmed S: Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. Am J Physiol Endocrinol Metab 2002;282:E1110–E1118.
31.
Chesnokova V, Melmed S: Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation. Endocrinology 2000;141:4032–4040.
32.
LeMay LG, Vander AJ, Kluger MJ: Role of interleukin-6 in fever in rats. Am J Physiol 1990;258:R798–R803.
33.
Vankelecom H, Matthys P, Van Damme J, Heremans H, Billiau A, Denef C: Immunocytochemical evidence that S-100-positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity. J Histochem Cytochem 1993;41:151–156.
34.
Bousquet C, Ray DW, Melmed S: A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem 1997;272:10551–10557.
35.
Bousquet C, Zatelli MC, Melmed S: Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest 2000;106:1417–1425.
36.
Li QL, Jansen E, Friedman TC: Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines. Mol Cell Endocrinol 1999;158:143–152.
37.
Auernhammer CJ, Melmed S: The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest 2001;108:1735–1740.
38.
Chesnokova V, Auernhammer CJ, Melmed S: Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 1998;139:2209–2216.
39.
Wanatobe H, Suda T: A significant role of leukemia inhibitory factor in the brain and periphery in endotoxin stimulation of adrenocorticotropin secretion in the rat. Brain Res 2000;865:97–101.
40.
Matsunaga W, Osawa S, Miyata S, Kiyohara T: Astrocytic Fos expression in the rat posterior pituitary following LPS administration. Brain Res 2001;898:215–223.
41.
Turnbull AV, Rivier CL: Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999;79:1–71.
42.
Aubry JM, Turnbull AV, Pozzoli G, Rivier C, Vale W: Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary. Endocrinology 1997;138:1621–1626.
43.
Autelitano DJ, Cohen DR: CRF stimulates expression of multiple fos and jun related genes in the AtT-20 corticotroph cell. Mol Cell Endocrinol 1996;17:25–35.
44.
Boutillier AL, Sassone-Corsi P, Loeffler JP: The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells. Mol Endocrinol 1991;5:1301–1310.
45.
Callahan TA, Piekut DT: Differential Fos expression induced by IL-1beta and IL-6 in rat hypothalamus and pituitary gland. J Neuroimmunol 1997;73:207–211.
46.
Venihaki M, Dikkes P, Carrigan A, Karalis KP: Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 2001;108:1159–1166.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.